Franklin Resources
CNTX icon

Franklin Resources’s Context Therapeutics CNTX Stock Holding History

Franklin Resources’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,803,338
Closed -$2.11M – 3214
2026
Q2 		$2.11M Hold
3,803,338
– – ﹤0.01% 1983
2026
Q1 		$10M Sell
3,803,338
-200,042
-5% -$467K ﹤0.01% 1245
2025
Q4 		$5.88M Hold
4,003,380
– – ﹤0.01% 1336
2025
Q3 		$3.88M Hold
4,003,380
– – ﹤0.01% 1526
2025
Q2 		$2.62M Hold
4,003,380
– – ﹤0.01% 1614
2025
Q1 		$2.45M Hold
4,003,380
– – ﹤0.01% 1614
2024
Q4 		$4.2M Buy
4,003,380
+2,149,392
+116% +$3.72M ﹤0.01% 1422
2024
Q3 		$3.69M Buy
+1,853,988
New +$4.11M ﹤0.01% 1490

Other funds holding CNTX

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Landscape Capital Management
Landscape Capital Management Englewood, New Jersey $1.34B AUM 18.69% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

Franklin Resources's CNTX Position: Q3 2026 in Review

Franklin Resources sold out of Context Therapeutics (CNTX) in Q3 2026, closing a stake of 3,803,338 shares — an estimated $2.11M sold.

Franklin Resources first reported a position in CNTX in Q3 2024 and held it in 8 quarters. The position peaked at $10M in Q1 2026. 47 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.

  • Franklin Resources reported no remaining Context Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Franklin Resources sold 3,803,338 Context Therapeutics shares in Q3 2026, an estimated $2.11M.
  • Franklin Resources first reported a position in Context Therapeutics in Q3 2024 and held it in 8 quarters.
  • Franklin Resources's Context Therapeutics position peaked at $10M in Q1 2026.
  • 47 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.